Inari Medical Stock Analysis

NARI Stock  USD 51.03  0.20  0.39%   
Inari Medical is undervalued with Real Value of 66.06 and Target Price of 83.1. The main objective of Inari Medical stock analysis is to determine its intrinsic value, which is an estimate of what Inari Medical is worth, separate from its market price. There are two main types of Inari Medical's stock analysis: fundamental analysis and technical analysis.
The Inari Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Inari Medical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.

Inari Stock Analysis Notes

About 96.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 275.35. Inari Medical recorded a loss per share of 1.35. The entity had not issued any dividends in recent years. Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. Inari Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 800 people. To find out more about Inari Medical contact William Hoffman at 877 923 4747 or learn more at https://www.inarimedical.com.

Inari Medical Quarterly Total Revenue

153.39 Million

Inari Medical Investment Alerts

Inari Medical had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 493.63 M. Net Loss for the year was (1.64 M) with profit before overhead, payroll, taxes, and interest of 338.96 M.
Inari Medical has a frail financial position based on the latest SEC disclosures
Over 96.0% of the company shares are owned by institutional investors
Latest headline from thelincolnianonline.com: Insider Selling Inari Medical, Inc. Director Sells 60,000 Shares of Stock

Inari Medical Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Inari Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
26th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Inari Largest EPS Surprises

Earnings surprises can significantly impact Inari Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-02-23
2021-12-310.030.02-0.0133 
2021-08-10
2021-06-300.080.07-0.0112 
2024-04-30
2024-03-31-0.2-0.22-0.0210 
View All Earnings Estimates

Inari Medical Environmental, Social, and Governance (ESG) Scores

Inari Medical's ESG score is a quantitative measure that evaluates Inari Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Inari Medical's operations that may have significant financial implications and affect Inari Medical's stock price as well as guide investors towards more socially responsible investments.

Inari Stock Institutional Investors

Shares
Jpmorgan Chase & Co2024-06-30
1.2 M
Bamco Inc2024-09-30
M
American Century Companies Inc2024-09-30
979.4 K
Mackenzie Investments2024-09-30
853.8 K
Point72 Asset Management, L.p.2024-09-30
805.6 K
Manufacturers Life Insurance Co2024-09-30
795.1 K
Fuller & Thaler Asset Management Inc2024-09-30
768.5 K
Bank Of America Corp2024-06-30
667.2 K
Dimensional Fund Advisors, Inc.2024-09-30
658 K
Blackrock Inc2024-06-30
8.4 M
Vanguard Group Inc2024-09-30
5.6 M
Note, although Inari Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Inari Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.99 B.

Inari Profitablity

The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.04) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.04.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.01)(0.01)
Return On Capital Employed(0.02)(0.02)

Management Efficiency

Inari Medical has return on total asset (ROA) of (0.0321) % which means that it has lost $0.0321 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1772) %, meaning that it created substantial loss on money invested by shareholders. Inari Medical's management efficiency ratios could be used to measure how well Inari Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.0056. The current Return On Capital Employed is estimated to decrease to -0.02. As of now, Inari Medical's Non Currrent Assets Other are increasing as compared to previous years. The Inari Medical's current Other Assets is estimated to increase to about 949.3 K, while Other Current Assets are projected to decrease to under 6 M.
Last ReportedProjected for Next Year
Book Value Per Share 8.19  8.60 
Tangible Book Value Per Share 1.76  2.54 
Enterprise Value Over EBITDA 242.25  230.13 
Price Book Value Ratio 7.93  8.32 
Enterprise Value Multiple 242.25  230.13 
Price Fair Value 7.93  8.32 
Enterprise Value3.7 B2.4 B
The strategic initiatives led by Inari Medical's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Operating Margin
(0.04)
Profit Margin
(0.14)
Beta
0.963
Return On Assets
(0.03)
Return On Equity
(0.18)

Technical Drivers

As of the 29th of November, Inari Medical retains the Market Risk Adjusted Performance of 0.9052, risk adjusted performance of 0.0769, and Downside Deviation of 2.19. Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Inari Medical, as well as the relationship between them.

Inari Medical Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Inari Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Inari Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Inari Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inari Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inari Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Inari Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Inari Medical Outstanding Bonds

Inari Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Inari Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Inari bonds can be classified according to their maturity, which is the date when Inari Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Inari Medical Predictive Daily Indicators

Inari Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Inari Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Inari Medical Corporate Filings

F4
22nd of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
20th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F3
18th of November 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
13A
8th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
7th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
31st of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
28th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
23rd of October 2024
An amended filing to the original Schedule 13G
ViewVerify

Inari Medical Forecast Models

Inari Medical's time-series forecasting models are one of many Inari Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Inari Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Inari Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Inari Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Inari shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Inari Medical. By using and applying Inari Stock analysis, traders can create a robust methodology for identifying Inari entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.01  0.01 
Operating Profit Margin(0.03)(0.03)
Gross Profit Margin 0.88  0.70 

Current Inari Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Inari analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Inari analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
83.1Strong Buy15Odds
Inari Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Inari analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Inari stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Inari Medical, talking to its executives and customers, or listening to Inari conference calls.
Inari Analyst Advice Details

Inari Stock Analysis Indicators

Inari Medical stock analysis indicators help investors evaluate how Inari Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Inari Medical shares will generate the highest return on investment. By understating and applying Inari Medical stock analysis, traders can identify Inari Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow60.2 M
Common Stock Shares Outstanding56.8 M
Total Stockholder Equity464.9 M
Tax Provision5.9 M
Quarterly Earnings Growth Y O Y-0.839
Property Plant And Equipment Net69.3 M
Cash And Short Term Investments115.5 M
Cash38.6 M
Accounts Payable10.6 M
Net Debt-6.5 M
50 Day M A45.996
Total Current Liabilities76.3 M
Other Operating Expenses507.7 M
Non Current Assets Total438.7 M
Forward Price Earnings232.5581
Non Currrent Assets Other2.6 M
Stock Based Compensation40.3 M

Complementary Tools for Inari Stock analysis

When running Inari Medical's price analysis, check to measure Inari Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inari Medical is operating at the current time. Most of Inari Medical's value examination focuses on studying past and present price action to predict the probability of Inari Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inari Medical's price. Additionally, you may evaluate how the addition of Inari Medical to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments